Earnings Feed
Start Free
Home/Filings/4/0001231919-25-000196
4//SEC Filing

PARMAR KUSH 4

Accession 0001231919-25-000196

CIK 0001736730other
View on SEC.govCompany Profile

Filed

Sep 14, 8:00 PM ET

Accepted

Sep 15, 8:12 PM ET

Size

18.7 KB

Accession

0001231919-25-000196

Insider Transaction Report

Form 4
Period: 2025-09-11
Camp4 Therapeutics CorpCAMP
5AM Ventures VI, L.P.
10% Owner
Transactions
  • Purchase

    Common Stock

    2025-09-11$1.53/sh+2,941,176$4,499,999→ 2,941,176 total(indirect: By 5AM Ventures VII, L.P.)
Holdings

  • Common Stock

    (indirect: By 5AM Ventures VI, L.P.)
    2,625,145

  • Common Stock

    (indirect: By 5AM Opportunities II, L.P.)
    302,770
5AM Partners VI, LLC
10% Owner
Transactions
  • Purchase

    Common Stock

    2025-09-11$1.53/sh+2,941,176$4,499,999→ 2,941,176 total(indirect: By 5AM Ventures VII, L.P.)
Holdings

  • Common Stock

    (indirect: By 5AM Opportunities II, L.P.)
    302,770

  • Common Stock

    (indirect: By 5AM Ventures VI, L.P.)
    2,625,145
5AM Ventures VII, L.P.
10% Owner
Transactions
  • Purchase

    Common Stock

    2025-09-11$1.53/sh+2,941,176$4,499,999→ 2,941,176 total(indirect: By 5AM Ventures VII, L.P.)
Holdings

  • Common Stock

    (indirect: By 5AM Opportunities II, L.P.)
    302,770

  • Common Stock

    (indirect: By 5AM Ventures VI, L.P.)
    2,625,145
5AM Opportunities II (GP), LLC
10% Owner
Transactions
  • Purchase

    Common Stock

    2025-09-11$1.53/sh+2,941,176$4,499,999→ 2,941,176 total(indirect: By 5AM Ventures VII, L.P.)
Holdings

  • Common Stock

    (indirect: By 5AM Ventures VI, L.P.)
    2,625,145

  • Common Stock

    (indirect: By 5AM Opportunities II, L.P.)
    302,770
5AM Opportunities II, L.P.
10% Owner
Transactions
  • Purchase

    Common Stock

    2025-09-11$1.53/sh+2,941,176$4,499,999→ 2,941,176 total(indirect: By 5AM Ventures VII, L.P.)
Holdings

  • Common Stock

    (indirect: By 5AM Ventures VI, L.P.)
    2,625,145

  • Common Stock

    (indirect: By 5AM Opportunities II, L.P.)
    302,770
5AM Partners VII, LLC
10% Owner
Transactions
  • Purchase

    Common Stock

    2025-09-11$1.53/sh+2,941,176$4,499,999→ 2,941,176 total(indirect: By 5AM Ventures VII, L.P.)
Holdings

  • Common Stock

    (indirect: By 5AM Opportunities II, L.P.)
    302,770

  • Common Stock

    (indirect: By 5AM Ventures VI, L.P.)
    2,625,145
PARMAR KUSH
10% Owner
Transactions
  • Purchase

    Common Stock

    2025-09-11$1.53/sh+2,941,176$4,499,999→ 2,941,176 total(indirect: By 5AM Ventures VII, L.P.)
Holdings

  • Common Stock

    (indirect: By 5AM Ventures VI, L.P.)
    2,625,145

  • Common Stock

    (indirect: By 5AM Opportunities II, L.P.)
    302,770
Footnotes (3)
  • [F1]The shares are directly held by 5AM Ventures VII, L.P. ("Ventures VII"). 5AM Partners VII, LLC ("Partners VII") is the sole general partner of Ventures VII. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VII and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VII. Each of Partners VII and Dr. Parmar disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports.
  • [F2]The shares are directly held by 5AM Ventures VI, L.P. ("Ventures VI"). 5AM Partners VI, LLC ("Partners VI") is the sole general partner of Ventures VI. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VI and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VI. Each of Partners VI and Dr. Parmar disclaims beneficial ownership of such shares except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports.
  • [F3]The shares are directly held by 5AM Opportunities II, L.P. ("Opportunities II"). 5AM Opportunities II (GP), LLC ("Opportunities II GP") is the sole general partner of Opportunities II. Andrew J. Schwab and Dr. Kush Parmar are the managing members of Opportunities II GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities II. Each of Opportunities II GP and Dr. Parmar disclaims beneficial ownership of such shares, except to the extent of its or his respective pecuniary interest therein. Mr. Schwab is a director of the Issuer and files separate Section 16 reports.

Documents

1 file

Issuer

Camp4 Therapeutics Corp

CIK 0001736730

→
Entity typeother

Related Parties

1
  • filerCIK 0001664281

Filing Metadata

Form type
4
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 8:12 PM ET
Size
18.7 KB
View on SEC.gov